Fig. 3
The pooled prevalence of TDF/FTC-associated drug resistance mutation in oral pre-exposure prophylaxis arm after enrolment. ES Effect size equivalent to prevalence, CI confidence interval
Fig. 3 | AIDS Research and Therapy